Sherbrooke Park Advisers’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-9,057
Closed -$768K 371
2025
Q3
$768K Buy
9,057
+2,057
+29% +$163K 0.36% 68
2025
Q2
$477K Buy
7,000
+805
+13% +$51K 0.21% 190
2025
Q1
$375K Buy
+6,195
New +$432K 0.17% 219
2024
Q3
Sell
-24,707
Closed -$1.5M 1065
2024
Q2
$1.5M Buy
24,707
+8,571
+53% +$485K 0.26% 84
2024
Q1
$919K Buy
16,136
+10,936
+210% +$656K 0.18% 173
2023
Q4
$327K Sell
5,200
-27,023
-84% -$1.53M 0.15% 244
2023
Q3
$1.86M Buy
32,223
+20,123
+166% +$1.27M 0.59% 18
2023
Q2
$753K Buy
12,100
+3,200
+36% +$214K 0.4% 74
2023
Q1
$643K Buy
+8,900
New +$696K 0.97% 17

Other funds holding INCY

Sherbrooke Park Advisers's INCY Position: Q4 2025 in Review

Sherbrooke Park Advisers sold out of Incyte (INCY) in Q4 2025, closing a stake of 9,057 shares — an estimated $768K sold.

Sherbrooke Park Advisers first reported a position in INCY in Q1 2023 and held it in 9 quarters. The position peaked at $1.86M in Q3 2023. 821 funds tracked by Wall St. Rank hold INCY as of Q4 2025.

  • Sherbrooke Park Advisers reported no remaining Incyte position as of Q4 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 9,057 Incyte shares in Q4 2025, an estimated $768K.
  • Sherbrooke Park Advisers first reported a position in Incyte in Q1 2023 and held it in 9 quarters.
  • Sherbrooke Park Advisers's Incyte position peaked at $1.86M in Q3 2023.
  • 821 funds tracked by Wall St. Rank held Incyte as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.